NCT05907772View on ClinicalTrials.gov

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

522

Participants

Timeline

Start Date

August 27, 2022

Primary Completion Date

October 25, 2022

Study Completion Date

November 10, 2022

Conditions
Cancer of Liver
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

310003

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER